i iii (Vector Laboratories)
Structured Review
I Iii, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 65 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bk-3000/Lectin+Kit+III%2C+Biotinylated/pm41375532-50-18-19
Average 94 stars, based on 65 article reviews
Images
Related Articles
Incubation:Article Title: Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines. Article Snippet: In situ vaccination (ISV) strategies offer an innovative approach to cancer immunotherapy by utilizing drug combinations directly at tumor sites to elicit personalized immune responses.. Tumor cell-derived extracellular vesicles (TEVs) in ISV have great potential but face challenges such as low release rates and immunosuppressive proteins like programmed death ligand 1 (PD-L1) and CD47.. This study develops a nanoparticle-based ISV strategy (Combo-NPs@shGNE) that enhances TEV release and modulates cargo composition. Article Title: MSC-sEVs exacerbate senescence by transferring bisecting GlcNAcylated GPNMB Article Snippet: .. The membranes were soaked in 3% (w/v) BSA in TBST at 37 °C for 2 h. The membranes were incubated with Article Title: MSC-sEVs exacerbate senescence by transferring bisecting GlcNAcylated GPNMB. Article Snippet: .. The membranes were soaked in 3% (w/v) BSA in TBST at 37 °C for 2 h. The membranes were incubated with Staining:Article Title: Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines. Article Snippet: In situ vaccination (ISV) strategies offer an innovative approach to cancer immunotherapy by utilizing drug combinations directly at tumor sites to elicit personalized immune responses.. Tumor cell-derived extracellular vesicles (TEVs) in ISV have great potential but face challenges such as low release rates and immunosuppressive proteins like programmed death ligand 1 (PD-L1) and CD47.. This study develops a nanoparticle-based ISV strategy (Combo-NPs@shGNE) that enhances TEV release and modulates cargo composition. Labeling:Article Title: UDP-glucuronic acid availability underlies sex difference in renal expression of nonsulfated Human Natural Killer-1 (HNK-1) glycans Article Snippet: For lectin blotting, membranes were blocked with Blocking One (Cat#03953–95, Nacalai Tesque) and incubated with HRP- or biotin-conjugated lectins diluted in 5% Blocking One in PBST. .. When other:Article Title: EASyMap-Guided Stepwise One-Pot Multienzyme (StOPMe) Synthesis and Multiplex Assays Identify Functional Tetraose-Core-Human Milk Oligosaccharides Article Snippet: Proteins were purified using Bio-ScaleTM Mini ProfinityTM TMAC (5 mL) cartridges in a NGC QUEST 10 Chromatography System from Bio-Rad. |
